Home › Funds › GENERAL AMERICAN INVESTORS CO INC › SPRY
GENERAL AMERICAN INVESTORS CO INC position in SPRY
ARS PHARMACEUTICALS INC · Health Care
GENERAL AMERICAN INVESTORS CO INC reported holding 1,133,046 shares of SPRY (ARS PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$9.1M, representing 0.55% of its reported portfolio and ranking #47 among its reported holdings. GENERAL AMERICAN INVESTORS CO INC has disclosed SPRY holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How GENERAL AMERICAN INVESTORS CO INC's SPRY position evolved
GENERAL AMERICAN INVESTORS CO INC first disclosed a stake in SPRY in Q4 2025 at 559,959 shares (US$6.5M). The position peaked in Q2 2026 at 1,133,046 shares, worth US$9.1M. Across 3 filings, GENERAL AMERICAN INVESTORS CO INC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,133,046 shares valued at US$9.1M — an increase of 405,892 shares quarter over quarter.. Notable position changes include a 30% increase in Q1 2026 (shares were roughly flat over the following quarter), a 56% increase in Q2 2026 (shares fell 46% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 559.96K | $6.52M | New |
| Q1 2026 | 727.15K | $5.84M | Add |
| Q2 2026 | 1.13M | $9.08M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SPRY and 13F data
SPRY (ARS PHARMACEUTICALS INC) is a Health Care company. 24 other funds we track also report a position in SPRY — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$87.0M), Rubric Capital Management LP (US$68.4M), ORBIMED ADVISORS LLC (US$66.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SPRY
- RA CAPITAL MANAGEMENT, L.P. 10.86M sh · $87.00M · Q2 2026
- Rubric Capital Management LP 8.54M sh · $68.41M · Q2 2026
- ORBIMED ADVISORS LLC 8.29M sh · $66.39M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 7.50M sh · $60.11M · Q2 2026
- Tyro Capital Management LLC 4.46M sh · $35.72M · Q2 2026
- SR ONE CAPITAL MANAGEMENT, LP 4.01M sh · $32.14M · Q2 2026
- Third Point 1.00M sh · $8.01M · Q2 2026
- Third Point LLC 1.00M sh · $8.01M · Q2 2026
- Tejara Capital Ltd 607.04K sh · $4.86M · Q2 2026
More on GENERAL AMERICAN INVESTORS CO INC
FAQ
How long has GENERAL AMERICAN INVESTORS CO INC held SPRY?
GENERAL AMERICAN INVESTORS CO INC has disclosed SPRY holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is GENERAL AMERICAN INVESTORS CO INC's current position in SPRY?
As of Q2 2026, GENERAL AMERICAN INVESTORS CO INC holds 1.13M shares of SPRY (ARS PHARMACEUTICALS INC), valued at $9.08M, representing 0.55% of its reported portfolio and ranking #47.
Has GENERAL AMERICAN INVESTORS CO INC been buying or selling SPRY?
In the latest 13F filing (Q2 2026), GENERAL AMERICAN INVESTORS CO INC increased its position in SPRY. The position peaked in Q2 2026 at 1.13M shares.
Which other funds hold SPRY?
Other major institutional holders of SPRY include RA CAPITAL MANAGEMENT, L.P., Rubric Capital Management LP, ORBIMED ADVISORS LLC, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.